Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-19

Clinical Trial Update: EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Novaremed for Painful Diabetic Neuropathy under EPPIC-Net has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Novaremed

Snippet

Sponsor: James P. Rathmell, MD | Conditions: Painful Diabetic Neuropathy | Phase 2 | Status: COMPLETED